Ledger.Open graph →
SEC Form D · filed August 23, 2022

Orna Therapeutics Holdings, LLC

Offering
$300.0M
Sold
$120.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Sakae M. Asanuma · Cambridge, MADirectorJohn M. Mccabe · Cary, NCExecMorana M. Jovan-Embiricos · Cambridge, MADirectorAnsbert M. Gadicke · Cambridge, MADirectorBrian M. Goodman · Cambridge, MADirectorDaniel M. Anderson · Cambridge, MADirectorRobert M. Marby · Cambridge, MAExecJohn M. Mccabe · Cambridge, MAExecWilliam M. Shen · Cambridge, MAExecNishla M. Keiser · Cambridge, MAExecThomas M. Ebeling · Cambridge, MADirectorFrancesco M. Marincola · Cambridge, MADirectorThomas M. Barnes · Cambridge, MAExec · DirectorBrian M. Goodman · Cambridge, MADirectorSakae M. Asanuma · Cambridge, MADirectorDaniel M. Anderson · Cambridge, MADirectorRobert M. Marby · Cambridge, MAExecJohn M. Mccabe · Cambridge, MAExecWilliam M. Shen · Cambridge, MAExecMorana M. Jovan-Embiricos · Cambridge, MADirectorNishla M. Keiser · Cambridge, MAExecThomas M. Ebeling · Cambridge, MADirectorFrancesco M. Marincola · Cambridge, MADirectorAnsbert M. Gadicke · Cambridge, MADirectorThomas M. Barnes · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗